As a non-profit organization, ASCO has been engaged ever since 1964 in supporting all types of cancer research, but especially patient-oriented clinical research. The function of ASCO is based on four main pillars: facilitating the provision of high-quality clinical care; promoting the exchange of information and ideas relating to cancer, including biology, diagnosis, technology, treatment and the psychosocial impact of cancer; assisting the training of all people in clinical research and the overall care of cancer patients; and fomenting optimal communication between the different branches involved in the study and treatment of cancer.
The EORTC Gynaecological Cancer Group has increased it’s collaboration with different other groups substantially. We collaborate with the following groups : EORTC Clinical Trial Group, NCIC-Canada, Scottish Gynaecological Cancer Group, Nordic Society of Gynaecological Cancer (NSGO), Medical Research Council (MRC, UK), Gynaecological Oncology Group (GOG-US), Arbeitsgemeinschaft fûr Gynekologische Onkologie (AGO – Germany). Representatives from each group usually attend the meetings and this is reciprocal whenever possible.
In addition the EORTC-GCG is one of the founding members of the Gynaecological Cancer Intergroup. In this group most multicentric groups, studying gynaecological cancer, are represented and meet twice a year.
The Gynecologic Cancer Intergroup (GCIG) is an organization in which the representatives of the different international and national research groups conducting clinical gynaecological cancer trials take part.